Hospira Expands Board of Directors
09 Março 2009 - 2:04PM
PR Newswire (US)
LAKE FOREST, Ill., March 9 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a leading global specialty pharmaceutical and
medication delivery company, announced today that Heino von
Prondzynski has been elected to the company's board of directors.
Von Prondzynski brings strong executive management and diverse
global experience from leadership positions held at multinational
healthcare companies. The addition of von Prondzynski expands
Hospira's board to 10 directors, of whom nine are independent.
"Heino has an impressive track record of achievement in the
healthcare industry and significant experience in delivering global
growth and expansion," said Christopher B. Begley, chairman and
chief executive officer. "His interest in talent development and
passion for driving product innovation also make him an excellent
and complementary addition to the Hospira board." Von Prondzynski,
59, served as chief executive officer of Roche Diagnostics and as a
member of the executive committee of F. Hoffman-La Roche Ltd. from
early 2000 to 2005, retiring from Roche at the end of 2006. While
at Roche, he brought Roche Diagnostics, which included diabetes,
near-patient testing, centralized diagnostics and applied science
to global market leadership and record industry-standard
profitability ratios. He also drove significant growth through an
expansion of the molecular diagnostics portfolio and entrance into
the blood-screening market. From 1996 to 2000, von Prondzynski held
several executive positions, including president of its vaccine
business, at Chiron Corporation, a multinational firm that develops
biopharmaceuticals, vaccines and blood-testing products. Earlier in
his career, von Prondzynski held sales and marketing and general
management positions at Bayer A.G. Von Prondzynski is on the boards
of Koninklijke Philips Electronics N.V. (Royal Philips Electronics
Inc.), Qiagen N.V., BB Medtech A.G. and Epigenomics A.G. Born in
Germany, now living in Switzerland, von Prondzynski studied
mathematics, geography and history at Westfalische Wilhelms
University of Munster in Germany. About Hospira Hospira, Inc. is a
global specialty pharmaceutical and medication delivery company
dedicated to Advancing Wellness(TM). As the world leader in
specialty generic injectable pharmaceuticals, Hospira offers one of
the broadest portfolios of generic acute-care and oncology
injectables, as well as integrated infusion therapy and medication
management solutions. Through its products, Hospira helps improve
the safety, cost and productivity of patient care. The company is
headquartered in Lake Forest, Ill., and has more than 14,000
employees. Learn more at http://www.hospira.com/. DATASOURCE:
Hospira, Inc. CONTACT: Media, Tareta Adams, +1-224-212-2535, or
Investors, Karen King, +1-224-212-2711, both of Hospira, Inc. Web
Site: http://www.hospira.com/
Copyright